Silke Frenz

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

Katrin Mestermann, Theodoros Giavridis, Justus Weber et al. · Science Translational Medicine · 2019 · 484 citations · Full text

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Hardikkumar Jetani, Almudena Navarro‐Bailón, Marius Maucher et al. · Blood · 2021 · 97 citations · Full text

CAR T cells targeting α_vβ₃integrin are effective against advanced cancer in preclinical models

Lars Wallstabe, Andreas Mades, Silke Frenz et al. · Advances in Cell and Gene Therapy · 2018 · 57 citations

All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells

Estefanía García‐Guerrero, Luis Gerardo Rodríguez‐Lobato, Belén Sierro-Martínez et al. · Haematologica · 2022 · 29 citations · Full text